Structure | Chemical Name | CAS | MF |
|
ParB protein, phage P1
|
|
|
|
parazoanthoxanthin A
|
|
|
|
ParB protein, E. coli
|
|
|
|
parchorin
|
|
|
|
PARDAXIN MOSES SOLE
|
67995-63-5
|
C154H248N36O45
|
|
p-ARBUTIN extrapure for biochemistry
|
|
|
|
Parconazole
|
61400-59-7
|
C17H16Cl2N2O3
|
|
PARECOXIB NA
|
197502-82-2
|
C19H17N2NaO4S
|
|
Parecoxib sodium
|
|
|
|
Parecoxib
|
|
|
|
PARECOXIB SODIUM
|
198470-85-8
|
C19H17N2NaO4S
|
|
parD protein
|
|
|
|
P3A1 regulatory protein
|
139874-92-3
|
|
|
paregoric
|
8029-99-0
|
|
|
P3A2 regulatory protein
|
139874-93-4
|
|
|
pareirubrine B
|
152845-78-8
|
|
|
pareirubrine A
|
147044-68-6
|
|
|
pare isopropyl phenol polyoxyethylene (9~10) ether
|
|
C27~29H48~52O10~11
|
|
parent Yellow 3GR
|
|
|
|
PARFDEODALLIV
|
|
|
|
PARENTALSMOKING
|
|
|
|
parentrovite
|
53262-66-1
|
|
|
PARENTERAL HYPERALIMENTATION FLUID, DOG
|
|
|
|
Parepectolin
|
|
|
|
Pareptide
|
61484-38-6
|
C14H26N4O3
|
|
Pareptide sulfate
|
61484-39-7
|
|
|
(-)-pareruptorin A
|
|
|
|
papyriflavonol A
|
|
|
|
papyriogenin C
|
72933-75-6
|
|
|
papyracon D
|
|
|
|
PARG
|
|
|
|
P(BHET-EOP/BHET)
|
|
|
|
Parex-paraffin
|
|
|
|
PAR-1 FORMULA
|
|
|
|
PARGEVERINE HCL
|
13479-13-5
|
C21H24ClNO3
|
|
P14ARF,P16,14KD,RABBITANTI-HUMAN:PARAFFIN,IH
|
|
|
|
P14ARF,P16,RABBITANTI-
|
|
|
|
p14ARF Protein
|
|
|
|
PAQ2 protein
|
|
|
|
PAQ1 protein
|
|
|
|
Par h 1 allergen
|
|
|
|
Pargolol
|
47082-97-3
|
C16H23NO3
|
|
PC2
|
|
C18H29N5O10S2
|
|
4-Aminosalicylic acid
|
65-49-6
|
C7H7NO3
|
|
P-16-C
|
|
|
|
08:0 PC
|
|
C24H48NO8P
|
|
PC 12
|
135949-54-1
|
|
|
PC 16
|
109897-91-8
|
|
|
PC 4
|
|
C34H53N9O18S4
|
|
03:0 PC
|
|
C14H28NO8P
|
|
P-C
|
|
|
|
p73 C
|
|
|
|
p107 C
|
|
|
|
p63 C
|
|
|
|
05:0 PC
|
|
C18H36NO8P
|
|
Parguerol 19-acetate
|
|
|
|
Parguerol 7-acetate
|
|
|
|
Parguerol
|
83115-36-0
|
|
|
Paricalcitol Solution
|
|
|
|
Paridocaine
|
7162-37-0
|
C17H26N2O2
|
|
paridiformoside
|
112468-35-6
|
|
|
PARIETERA
|
|
|
|
PARIETARIAJUDAICA
|
|
|
|
PARIETARIAOFFICINALIS
|
|
|
|
PARIETARIASPECIES
|
|
|
|
PARIETARIAPOLLEN
|
|
|
|
PARIETARIA
|
|
|
|
Parientin
|
|
|
|
pargyropyranone
|
72543-53-4
|
|
|
pargyline N-oxide
|
74796-01-3
|
|
|
PARGYLINE HCL USP(CRM STANDARD)
|
|
|
|
PARGYLINE HYDROCHLORIDE
|
306-07-0
|
C11H14ClN
|
|
Parietaria officinalis, ext.
|
84012-32-8
|
|
|
parieval
|
80244-05-9
|
|
|
PARIKA EXTRACT
|
|
|
|
2-parinarolyllecithin
|
77518-34-4
|
|
|
2-parinaroylphosphatidylinositol
|
|
|
|
parinaraldehyde
|
148408-16-6
|
|
|
parinaroyl-coenzyme A
|
|
|
|
parinol
|
|
|
|
Pariphyllin
|
|
|
|
PARIS VIOLET B BASE
|
|
|
|
06-Paris-LA-66 protocol
|
|
|
|
PARIS ROOT PLANT EXTRACT
|
|
|
|
Paris saponin I
|
64652-21-7
|
|
|
PARIS POLYPHLLA STEROIDAL SAPONINS:30%,50%,60%
|
|
|
|
PARK AND SANDERS SELECTIVE SUPPLEMENT II, MODIFIED
|
|
|
|
PARK AND SANDERS SELECTIVE SUPPLEMENT I
|
|
|
|
PARK AND SANDERS ENRICHMENT BROTH (BASE)
|
|
|
|
1/4" PARKER FERRULES, BRASS (5/PK)
|
|
|
|
parkeol
|
28032-52-2
|
|
|
Parker's fluid
|
|
|
|
1/4" PARKER PLUGS, BRASS
|
|
|
|
PARKIN N-TERMINAL PEPTIDE
|
|
C55H90N22O24S
|
|
PARKIATIMORIANA
|
|
|
|
PARKIASPECIOSA
|
|
|
|
PARKINGATTENDANTS
|
|
|
|
parkin protein
|
|
|
|
Parkin,N-Terminal
|
|
|
|
ParkinsonDisease(AutosomalRecessive,EarlyOnset)7,Park7(Dj-1)
|
|
|